» Articles » PMID: 7836696

Fibrogenic and Collagenolytic Activity in Carbon-tetrachloride-injured Rats: Beneficial Effects of Zinc Administration

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 1994 Sep 1
PMID 7836696
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Collagen synthesis and degradation in normal and carbon-tetrachloride-injured male Wistar rats at early and late stages of liver fibrosis, and the potential beneficial effects of zinc supplementation on liver fibrogenesis and collagenolysis have been assessed by measuring hepatic collagen content and prolyl hydroxylase and collagenase activities. No significant changes in hepatic collagen and prolyl hydroxylase activities were observed between control rats (82 +/- 25 cpm/mg protein) and rats with induced cirrhosis (107 +/- 23 cpm/mg protein) after 4 weeks of carbon tetrachloride injury. By this time, hepatic collagenase activity was significantly lower in rats with induced cirrhosis (61 +/- 9 micro units/mg protein) than in control rats (133 +/- 31 micro units/mg protein) (p < 0.05). This result was prevented by zinc administration, since hepatic collagenase activity was similar in zinc-supplemented, carbon-tetrachloride-injured rats and normal rats (148 +/- 19 micromicrons/mg protein). After 16 weeks, all carbon-tetrachloride-injured rats had cirrhosis. Hepatic collagen content and prolyl hydroxylase activity were significantly higher in carbon-tetrachloride-injured rats than in controls. These effects were partially prevented by zinc administration, since only two of the seven zinc-supplemented, carbon-tetrachloride-injured rats had cirrhosis. Moreover, prolyl hydroxylase activity was significantly lower in zinc-supplemented injured rats (263 +/- 27 cpm/mg protein) than in the non-supplemented respective controls (389 +/- 52 cpm/mg protein) (p < 0.05). No significant changes in hepatic collagenase activity were observed at this stage of liver injury.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

A randomized clinical study to evaluate the possible antifibrotic effect of zinc sulfate in chronic HCV patient receiving direct-acting anti-viral therapy.

El-Haggar S, Attalla D, Elhelbawy M, El-Afify D Inflammopharmacology. 2025; 33(1):329-339.

PMID: 39789197 PMC: 11799079. DOI: 10.1007/s10787-024-01628-3.


A novel adjustable PHBV basement film for enhancing the efficacy of glaucoma surgery by inhibiting scar formation.

Zhou D, Zhu W, Liu H, Zhang F, Zhou X, Zhang X Mater Today Bio. 2024; 24:100922.

PMID: 38226011 PMC: 10788518. DOI: 10.1016/j.mtbio.2023.100922.


Enzymes of Fibrosis in Chronic Liver Disease.

Tsomidis I, Notas G, Xidakis C, Voumvouraki A, Samonakis D, Koulentaki M Biomedicines. 2022; 10(12).

PMID: 36551935 PMC: 9776355. DOI: 10.3390/biomedicines10123179.


Tibetan Medical Formula Shi-Wei-Gan-Ning-Pill Protects Against Carbon Tetrachloride-Induced Liver Fibrosis - An NMR-Based Metabolic Profiling.

Feng X, Li M, Xia J, Deng Ba D, Ruan L, Xing Y Front Pharmacol. 2018; 9:965.

PMID: 30210344 PMC: 6123542. DOI: 10.3389/fphar.2018.00965.


Low Plasma Zinc Is Associated with Higher Mitochondrial Oxidative Stress and Faster Liver Fibrosis Development in the Miami Adult Studies in HIV Cohort.

Martinez S, Campa A, Li Y, Fleetwood C, Stewart T, Ramamoorthy V J Nutr. 2017; 147(4):556-562.

PMID: 28228506 PMC: 5368586. DOI: 10.3945/jn.116.243832.